Literature DB >> 7851173

Immediate vs. salvage resection after local treatment for early rectal cancer.

P L Baron1, W E Enker, M F Zakowski, C Urmacher.   

Abstract

PURPOSE: There is an increasing awareness of local procedures to treat early stage rectal cancer. Abdominoperineal resection (APR) or low anterior resection (LAR) has been recommended if adverse pathologic findings are encountered in the local excision specimen. No data compare the impact on survival of "immediate" resection for adverse features vs. "salvage" resection for clinical recurrence.
METHODS: We reviewed retrospectively 155 patients who underwent initial curative treatment of invasive rectal cancer by excision (91), snare-cautery (44), and fulguration (20).
RESULTS: Twenty-one patients underwent APR/LAR immediately after initial local treatment, whereas another 21 patients underwent salvage APR/LAR for local recurrence. The disease-free survival after APR/LAR was 94.1 percent for the immediate group and 55.5 percent for the delayed group (P < 0.05).
CONCLUSION: This decreased survival observed after delayed resection supports the recommendation for immediate APR/LAR when adverse pathologic features are present in the excision specimen.

Entities:  

Mesh:

Year:  1995        PMID: 7851173     DOI: 10.1007/bf02052447

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  25 in total

1.  Transanal endoscopic microsurgery for rectal cancer. Long-term oncologic results.

Authors:  Jose M Ramirez; Vicente Aguilella; Javier Valencia; Javier Ortego; Jose A Gracia; Pilar Escudero; Ricardo Esco; Mariano Martinez
Journal:  Int J Colorectal Dis       Date:  2011-01-27       Impact factor: 2.571

2.  T1 adenocarcinoma of the rectum: transanal excision or radical surgery?

Authors:  Hartmut Schäfer; Arnulf H Hölscher
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

3.  A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial.

Authors:  Julio Garcia-Aguilar; Qian Shi; Charles R Thomas; Emily Chan; Peter Cataldo; Jorge Marcet; David Medich; Alessio Pigazzi; Samuel Oommen; Mitchell C Posner
Journal:  Ann Surg Oncol       Date:  2011-07-14       Impact factor: 5.344

Review 4.  Transanal endoscopic microsurgery for rectal cancer: T1 and beyond? An evidence-based review.

Authors:  Marco E Allaix; Alberto Arezzo; Mario Morino
Journal:  Surg Endosc       Date:  2016-02-22       Impact factor: 4.584

5.  The Role of Transanal Surgery in the Management of T1 Rectal Cancers.

Authors:  Imran Hassan; Paul E Wise; David A Margolin; James W Fleshman
Journal:  J Gastrointest Surg       Date:  2015-06-06       Impact factor: 3.452

6.  Transanal Minimally Invasive Surgery (TAMIS): a clinical spotlight review.

Authors:  Teresa deBeche-Adams; Imran Hassan; Stephen Haggerty; Dimitrios Stefanidis
Journal:  Surg Endosc       Date:  2017-06-27       Impact factor: 4.584

7.  Salvage TME following TEM: a possible indication for TaTME.

Authors:  F Letarte; M Raval; A Karimuddin; P T Phang; C J Brown
Journal:  Tech Coloproctol       Date:  2018-05-04       Impact factor: 3.781

8.  Local management of rectal neoplasia.

Authors:  John Touzios; Kirk A Ludwig
Journal:  Clin Colon Rectal Surg       Date:  2008-11

9.  Previous transanal endoscopic microsurgery for rectal cancer represents a risk factor for an increased abdominoperineal resection rate.

Authors:  Mario Morino; Marco Ettore Allaix; Simone Arolfo; Alberto Arezzo
Journal:  Surg Endosc       Date:  2013-03-12       Impact factor: 4.584

10.  Local excision for ypT2 rectal cancer--much ado about something.

Authors:  Rodrigo O Perez; Angelita Habr-Gama; Igor Proscurshim; Fábio G Campos; Desiderio Kiss; Joaquim Gama-Rodrigues; Ivan Cecconello
Journal:  J Gastrointest Surg       Date:  2007-09-06       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.